Securian Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $498K | Buy |
4,694
+124
| +3% | +$13.2K | 0.01% | 686 |
|
2025
Q1 | $567K | Hold |
4,570
| – | – | 0.02% | 619 |
|
2024
Q4 | $563K | Sell |
4,570
-232
| -5% | -$28.6K | 0.02% | 643 |
|
2024
Q3 | $535K | Sell |
4,802
-220
| -4% | -$24.5K | 0.02% | 668 |
|
2024
Q2 | $536K | Sell |
5,022
-100
| -2% | -$10.7K | 0.02% | 649 |
|
2024
Q1 | $617K | Sell |
5,122
-225
| -4% | -$27.1K | 0.02% | 621 |
|
2023
Q4 | $658K | Hold |
5,347
| – | – | 0.02% | 580 |
|
2023
Q3 | $692K | Sell |
5,347
-334
| -6% | -$43.2K | 0.02% | 538 |
|
2023
Q2 | $704K | Sell |
5,681
-100
| -2% | -$12.4K | 0.02% | 574 |
|
2023
Q1 | $846K | Hold |
5,781
| – | – | 0.02% | 508 |
|
2022
Q4 | $921K | Hold |
5,781
| – | – | 0.03% | 477 |
|
2022
Q3 | $771K | Buy |
5,781
+100
| +2% | +$13.3K | 0.02% | 507 |
|
2022
Q2 | $886K | Buy |
5,681
+158
| +3% | +$24.6K | 0.02% | 539 |
|
2022
Q1 | $860K | Hold |
5,523
| – | – | 0.02% | 588 |
|
2021
Q4 | $704K | Buy |
5,523
+100
| +2% | +$12.7K | 0.01% | 665 |
|
2021
Q3 | $706K | Sell |
5,423
-100
| -2% | -$13K | 0.01% | 641 |
|
2021
Q2 | $981K | Buy |
5,523
+242
| +5% | +$43K | 0.02% | 569 |
|
2021
Q1 | $868K | Hold |
5,281
| – | – | 0.02% | 599 |
|
2020
Q4 | $872K | Sell |
5,281
-105
| -2% | -$17.3K | 0.02% | 557 |
|
2020
Q3 | $768K | Buy |
+5,386
| New | +$768K | 0.02% | 572 |
|